by admin | Mar 11, 2018 | News
Exogenus is developing promising therapeutics for the treatment of chronic and acute wounds, among which are diabetic foot ulcers, some of the most debilitating and hard-to-heal. The lead technology licensed and under development by Exogenus for the treatment of...
by admin | Feb 17, 2018 | News
Silvia Rodrigues, PhD student at Exogenus Therapeutics, presented a poster with results on research and development work done on the automatization of cord blood processing for production of an exosome-based medicinal product and its relevance for the scaling up...
by admin | Nov 8, 2017 | News
Exogenus was recognized at BioEurope 2017, one of the biggest biotech industry events! Listen to Joana Simões Correia on Exogenus Therapeutics: Event organizers, EBD Group and Johnson & Johnson Innovation, recognized how hard a task it was to choose the winner at...
by admin | Nov 2, 2017 | News
Exogenus was one of the 20 biotech startups selected to participate at Bio Europe 2017 Startup Slam taking place on November 7th in Berlin. Participants will have the chance to present in front of a jury of investors, dealmakers and biotech...
by admin | Oct 18, 2017 | News
Exogenus was distinguished as one of the most innovative Life Sciences & Medtech projects in Europe at Merck Venture Lounge, 2017! The Venture Lounge is an initiative of EASME through SME Instrument Phase 3...
by admin | Jul 10, 2017 | News
List of Exosome Companies: Tiny Packages, Enormous Potential “Recently, exosomes have been gaining momentum as a novel strategy for accessing the therapeutic effects of stem cells without the risks and difficulties of administering the cells to patients. Exosome...
